Sleep Medicine and Psychophysiology (수면정신생리)

KOREAN ACADEMY OF SLEEP MEDICINE (대한수면의학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Application of Digital Therapeutics for Insomnia

불면증 디지털 치료제의 임상 적용

  • Cho, Chul-Hyun (Department of Psychiatry, College of Medicine, Chungnam National University)
  • 조철현 (충남대학교 의과대학 정신과학교실)
  • Received : 2021.06.09
  • Accepted : 2021.06.23
  • Published : 2021.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Insomnia is one of the most common sleep disorders experienced by modern people, and treatment is often not adequate due to various limitations. Digital therapeutics for insomnia are expected to play a revolutionary role in supplementing and satisfying unmet needs in real-world clinical treatment. Digital therapeutics for insomnia were developed based on cognitive-behavioral therapy for insomnia, which is the first standard treatment for insomnia. The effectiveness of digital therapeutics for insomnia developed by several companies has been proven through well-designed clinical research. Various approaches have been used for practical application of digital therapeutics for insomnia. Thus far, meaningful results have been drawn, but there are areas that need to be improved upon based on real-world evidence. Sleep researchers need to validate the safe and effective application of digital therapeutics for the treatment of insomnia.

Keywords

Acknowledgement

이 논문은 정부(과학기술정보통신부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임(NRF-2020R1C1C1007463 and NRF-2021R1A5A8032895).

References

  1. Andersson G. The internet and CBT: a clinical guide, CRC Press; 2014.
  2. Budney AJ, Marsch LA, Aklin WM, Borodovsky JT, Brunette MF, Campbell AT, et al. Workshop on the development and evaluation of digital therapeutics for health behavior change: Science, methods, and projects. JMIR Mental Health 2020;7:e16751. https://doi.org/10.2196/16751
  3. Calem M, Bisla J, Begum A, Dewey M, Bebbington PE, Brugha T, et al. Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys. Sleep 2012; 35:377-384. https://doi.org/10.5665/sleep.1700
  4. Castelo-Branco L, Fregni F. Home-based transcranial direct current stimulation (tDCS) to prevent and treat symptoms related to stress: a potential tool to remediate the behavioral consequences of the COVID-19 isolation measures? Front Integr Neurosci 2020;14.
  5. Cheng P, Kalmbach DA, Tallent G, Joseph CL, Espie CA, Drake CL. Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial. Sleep 2019;42.
  6. Cho CH, Jee HJ, Nam YJ, An H, Kim L, Lee HJ. Temporal association between zolpidem medication and the risk of suicide: A 12-year population-based, retrospective cohort study. Sci Rep 2020;10:1-8. https://doi.org/10.1038/s41598-019-56847-4
  7. Cho CH, Lee HJ. Could digital therapeutics be a game changer in psychiatry? Psychiatry Investig 2019;16:97. https://doi.org/10.30773/pi.2019.01.20
  8. Cho CH, Lee HJ. Applying circadian rhythm concepts in digital healthcare. Chronobiol Med 2021;3:1-3. https://doi.org/10.33069/cim.2021.0006
  9. Cho CH, Lee HJ, Yoon HK, Kang SG, Bok KN, Jung KY, et al. Exposure to dim artificial light at night increases REM sleep and awakenings in humans. Chronobiol Int 2016;33:117-123. https://doi.org/10.3109/07420528.2015.1108980
  10. Cho CH, Lee T, Kim MG, In HP, Kim L, Lee HJ. Mood prediction of patients with mood disorders by machine learning using passive digital phenotypes based on the circadian rhythm: prospective observational cohort study. J Med Internet Res 2019;21:e11029. https://doi.org/10.2196/11029
  11. Cho CH, Lee T, Lee JB, Seo JY, Jee HJ, Son S, et al. Effectiveness of a smartphone app with a wearable activity tracker in preventing the recurrence of mood disorders: prospective case-control study. JMH 2020;7:e21283.
  12. Cho CH, Lee Y. The chronobiologic-based practical approach to shift work. Chronobiol Med 2019;1:103-106. https://doi.org/10.33069/cim.2019.0013
  13. Cho CH, Lee Y. The chronobiologic-based practical approach to shift work. Chronobiol Med 2019;1:103-106. https://doi.org/10.33069/cim.2019.0013
  14. Cho YW, Shin WC, Yun CH, Hong SB, Kim J, Earley CJ. Epidemiology of insomnia in Korean adults: prevalence and associated factors. J Clin Neurol (Seoul, Korea) 2009;5:20. https://doi.org/10.3988/jcn.2009.5.1.20
  15. Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care 2020;9:2207. https://doi.org/10.4103/jfmpc.jfmpc_105_20
  16. Darden M, Espie CA, Carl JR, Henry AL, Kanady JC, Krystal AD, et al. Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States. Sleep 2020;44.
  17. Elison S, Ward J, Williams C, Espie C, Davies G, Dugdale S, et al. Feasibility of a UK community-based, eTherapy mental health service in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the Full Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. BMJ Open 2017;7:e016392. https://doi.org/10.1136/bmjopen-2017-016392
  18. Erten Uyumaz B, Feijs L, Hu J. A review of digital cognitive behavioral therapy for insomnia (CBT-I Apps): are they designed for engagement? Int J Environ Res Public Health 2021;18:2929. https://doi.org/10.3390/ijerph18062929
  19. Espie CA, Emsley R, Kyle SD, Gordon C, Drake CL, Siriwardena AN, et al. Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical Trial. JAMA Psychiatry 2019;76:21-30. https://doi.org/10.1001/jamapsychiatry.2018.2745
  20. Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry 2020;77:484-492. https://doi.org/10.1001/jamapsychiatry.2019.4491
  21. Ferguson C, Hickman L, Wright R, Davidson PM, Jackson D. Preparing nurses to be prescribers of digital therapeutics. Contemp Nurse 2018;54:345-349. https://doi.org/10.1080/10376178.2018.1486943
  22. Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev 2015;23:54-67. https://doi.org/10.1016/j.smrv.2014.11.007
  23. Graham AK, Lattie EG, Mohr DC. Experimental therapeutics for digital mental health. JAMA Psychiatry 2019;76:1223-1224. https://doi.org/10.1001/jamapsychiatry.2019.2075
  24. Helgadottir FD, Menzies RG, Onslow M, Packman A, O'Brian S. Online CBT I: bridging the gap between Eliza and modern online CBT treatment packages. Behav Change 2009;26:245-253. https://doi.org/10.1375/bech.26.4.245
  25. Khirasaria R, Singh V, Batta A. Exploring digital therapeutics: The next paradigm of modern health-care industry. Perspectives in Clinical Research 2020;11:54. https://doi.org/10.4103/picr.PICR_89_19
  26. Kim HS. Apprehensions about excessive belief in digital therapeutics: points of concern excluding merits. Journal of Korean Medical Science 2020;35.
  27. Kuhn E, Weiss BJ, Taylor KL, Hoffman JE, Ramsey KM, Manber R, et al. CBT-I Coach: a description and clinician perceptions of a mobile app for cognitive behavioral therapy for insomnia. J Korean Med Sci 2016;12:597-606.
  28. Lee E. Cognitive behavioral treatment as a digital therapeutic for insomnia. Chronobiol Med 2020;2:10-15. https://doi.org/10.33069/cim.2020.0007
  29. Lee HA, Lee HJ, Moon JH, Lee T, Kim MG, In H, et al. Comparison of wearable activity tracker with actigraphy for sleep evaluation and circadian rest-activity rhythm measurement in healthy young adults. Psychiatry Investig 2017;14:179. https://doi.org/10.4306/pi.2017.14.2.179
  30. Lezard L. Pear Therapeutics Announces Second Closing of Series D Financing;2020.
  31. Lougheed T. How "digital therapeutics" differ from traditional health and wellness apps. CMAJ 2019;191:E1200. https://doi.org/10.1503/cmaj.1095801
  32. Morin CM. Cognitive-behavioral approaches to the treatment of insomnia. J Clin Psychiatry 2004;65(Suppl 16):33-40.
  33. Morin CM. Profile of somryst prescription digital therapeutic for chronic insomnia: overview of safety and efficacy. Expert Rev Med Devices 2020;17:1239-1248. https://doi.org/10.1080/17434440.2020.1852929
  34. Morin CM, Benca R. Chronic insomnia. The Lancet 2012;379:1129-1141. https://doi.org/10.1016/S0140-6736(11)60750-2
  35. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006;29:1398-1414. https://doi.org/10.1093/sleep/29.11.1398
  36. Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin 2013;8:281-297. https://doi.org/10.1016/j.jsmc.2013.05.002
  37. Nam YJ, Cho CH, Lee Y, Lee HJ. Development of safety usage guidelines for sedative hypnotics using the Delphi technique. Sleep Med Psychophysiol 2019;26:86-103. https://doi.org/10.14401/KASMED.2019.26.2.86
  38. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111. https://doi.org/10.1053/smrv.2002.0186
  39. Patel NA, Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics. NPJ Digit Med 2020;3:1-5. https://doi.org/10.1038/s41746-019-0211-0
  40. Perez-Pozuelo I, Zhai B, Palotti J, Mall R, Aupetit M, Garcia-Gomez JM, et al. The future of sleep health: a data-driven revolution in sleep science and medicine. NPJ Digit Med 2020;3:1-15. https://doi.org/10.1038/s41746-019-0211-0
  41. Pollack M, Seal B, Joish VN, Cziraky MJ. Insomnia-related comorbidities and economic costs among a commercially insured population in the United States. Curr Med Res Opin 2009;25: 1901-1911. https://doi.org/10.1185/03007990903035505
  42. Ranta K. The impact of user acceptance in the efficacy of digital therapeutics;2019.
  43. Recchia G, Capuano DM, Mistri N, Verna R. Digital Therapeutics-What they are, what they will be. Acta Sci Med Sci 2020;4:1-9.
  44. Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C, et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry 2017;74:68-75. https://doi.org/10.1001/jamapsychiatry.2016.3249
  45. Sasai T, Inoue Y, Komada Y, Nomura T, Matsuura M, Matsushima E. Effects of insomnia and sleep medication on health-related quality of life. Sleep Med 2010;11:452-457. https://doi.org/10.1016/j.sleep.2009.09.011
  46. Sivertsen B, Krokstad S, Overland S, Mykletun A. The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 2009;67:109-116. https://doi.org/10.1016/j.jpsychores.2009.05.001
  47. Soh HL, Ho RC, Ho CS, Tam WW. Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med 2020;75:315-325. https://doi.org/10.1016/j.sleep.2020.08.020
  48. Sverdlov O, Van Dam J, Hannesdottir K, Thornton-Wells T. Digital therapeutics: an integral component of digital innovation in drug development. Clin Pharmacol Ther 2018;104:72-80. https://doi.org/10.1002/cpt.1036
  49. Therapeutics P. Pear Therapeutics announces FDA submission for SomrystTM, a prescription digital therapeutic for the treatment of adults with chronic insomnia and depression;2020.
  50. Vedaa O, Kallestad H, Scott J, Smith ORF, Pallesen S, Morken G, et al. Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial. Lancet Digit Health 2020;2:e397-e406. https://doi.org/10.1016/S2589-7500(20)30135-7
  51. Vilponen J. Digital Therapeutics Solution and Business Model Creation: Multiple-case study through VISOR Lens;2019.
  52. Voinescu BI, Szentagotai A, David D. Internet-administered cognitive-behavioral therapy for insomnia. J Evid-Based Psychother 2013;13:225.
  53. Watson NF, Lawlor C, Raymann RJ. Will consumer sleep technologies change the way we practice sleep medicine? J Clin Sleep Med 2019;15:159-161. https://doi.org/10.5664/jcsm.7596
  54. Weatherall J, Khan FM, Patel M, Dearden R, Shameer K, Dennis G, et al. Clinical trials, real-world evidence, and digital medicine. The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry, Elsevier;2021. p.191-215.
  55. Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night's sleep. Sleep Med Rev 2016;30:72-82. https://doi.org/10.1016/j.smrv.2015.11.004
  56. Yap JY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci 2020;14.